Linklaters advised Samsung BioLogics on the deal.Samsung BioLogics, a Korean company active in the development and manufacturing of biopharmaceutical products worldwide, in its agreement with Biogen…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
